scispace - formally typeset
Book ChapterDOI

Basic Substance Characteristics and Neuropathological Findings in Drug Abusers

Reads0
Chats0
TLDR
In this article, the major psychoactive component, ∆9tetrahydrocannabinol (∆9-THC), interacts with specific CB receptors in the brain.
Abstract
Cannabis is the most frequently abused recreational drug worldwide. Its major psychoactive component, ∆9-tetrahydrocannabinol (∆9-THC), interacts with specific cannabinoid (CB) receptors in the brain. Until today distinct neuropathological alterations have not been described.

read more

References
More filters
Journal Article

Long-Term Effects of “Ecstasy” Use on Serotonin Transporters of the Brain Investigated by PET

TL;DR: The hypothesis of ecstasy-induced protracted alterations of the serotonin transporter (SERT) ligand support the hypothesis of reversibility of the availability of SERT as measured by PET, but this does not imply full reversal of the neurotoxic effects.
Journal ArticleDOI

The endocannabinoid system and psychiatric disorders.

TL;DR: SR141716A and cannabidiol show the most constant antipsychotic properties in dopamine- and glutamate-based models of schizophrenia, with profiles similar to an atypical antipsychotics drug.
Journal ArticleDOI

Levamisole: a dangerous new cocaine adulterant.

TL;DR: Levamisole was a US Food and Drug Administration–approved drug that has been used as an immunomodulator, a chemotherapy adjuvant, and anthelmintic medication, and has high abuse potential because of their amphetamine‐like pharmacological activity.
Journal ArticleDOI

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.

TL;DR: Recommendations for future toxicological testing of novel psychoactive substances include development and management of a national monitoring program to provide real-time clinical and toxicological data, confirmed analytically, on emerging drugs and their known toxidromes and side effect profiles.
Journal ArticleDOI

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans.

TL;DR: Although findings in animals are compelling, observations in humans are less clear, and it remains to be determined whether amphetamine analogues damage central monoaminergic neurons in humans and, if they do, whether functional consequences ensue.